Search

Insulet Corp

Cerrado

SectorSanidad

145.84 3.51

Resumen

Variación precio

24h

Actual

Mínimo

138.15

Máximo

143.3

Métricas clave

By Trading Economics

Ingresos

3.9M

95M

Ventas

40M

802M

P/B

Media del Sector

26.751

57.002

BPA

1.66

Margen de beneficios

11.85

Empleados

5,400

EBITDA

-22M

132M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+21.7% upside

Dividendos

By Acuity

Próximas Ganancias

5 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.8B

9.9B

Apertura anterior

142.33

Cierre anterior

145.84

Noticias sobre sentimiento de mercado

By Acuity

75%

25%

310 / 340 Clasificación en Healthcare

Insulet Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 ago 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14 ago 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13 ago 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

12 ago 2026, 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

11 ago 2026, 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

10 ago 2026, 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

7 ago 2026, 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6 ago 2026, 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5 ago 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 ago 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 ago 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 jul 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 jul 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 jul 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 jul 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 jul 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 jul 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 jul 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Comparación entre iguales

Cambio de precio

Insulet Corp previsión

Precio Objetivo

By TipRanks

21.7% repunte

Estimación a 12 Meses

Media 174.45 USD  21.7%

Máximo 216 USD

Mínimo 144 USD

De acuerdo con 23 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Insulet Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

23 ratings

13

Comprar

9

Mantener

1

Vender

Sentimiento

By Acuity

310 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat